294 related articles for article (PubMed ID: 17145896)
21. Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death.
Nilsson EM; Brokken LJ; Härkönen PL
Exp Cell Res; 2010 Mar; 316(5):800-12. PubMed ID: 19962979
[TBL] [Abstract][Full Text] [Related]
22. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells.
Block M; Gründker C; Fister S; Kubin J; Wilkens L; Mueller MD; Hemmerlein B; Emons G; Günthert AR
Int J Oncol; 2012 Nov; 41(5):1845-54. PubMed ID: 22922893
[TBL] [Abstract][Full Text] [Related]
24. RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway.
Zhang F; Wang Z; Yuan J; Wei X; Tian R; Niu R
Breast Cancer Res Treat; 2015 Sep; 153(2):263-75. PubMed ID: 26253946
[TBL] [Abstract][Full Text] [Related]
25. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
26. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
28. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc.
Ostrakhovitch EA; Cherian MG
Arch Biochem Biophys; 2004 Mar; 423(2):351-61. PubMed ID: 15001399
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
31. [siRNA-cyclin D1 inhibit cell proliferation in breast cancer MCF-7 cell line].
Jiang L; Chen RS; Li JC
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Apr; 39(2):118-22. PubMed ID: 16944582
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
[TBL] [Abstract][Full Text] [Related]
33. Arginine vasopressin inhibition of cyclin D1 gene expression blocks the cell cycle and cell proliferation in the mouse Y1 adrenocortical tumor cell line.
Schwindt TT; Forti FL; Juliano MA; Juliano L; Armelin HA
Biochemistry; 2003 Feb; 42(7):2116-21. PubMed ID: 12590600
[TBL] [Abstract][Full Text] [Related]
34. p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.
Carroll JS; Lynch DK; Swarbrick A; Renoir JM; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL
Cancer Res; 2003 Aug; 63(15):4322-6. PubMed ID: 12907598
[TBL] [Abstract][Full Text] [Related]
35. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells.
Saitoh M; Ohmichi M; Takahashi K; Kawagoe J; Ohta T; Doshida M; Takahashi T; Igarashi H; Mori-Abe A; Du B; Tsutsumi S; Kurachi H
Endocrinology; 2005 Nov; 146(11):4917-25. PubMed ID: 16123159
[TBL] [Abstract][Full Text] [Related]
36. UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.
He YY; Council SE; Feng L; Chignell CF
Cancer Res; 2008 May; 68(10):3752-8. PubMed ID: 18483258
[TBL] [Abstract][Full Text] [Related]
37. Involvement of Cx43 phosphorylation in 5'-N-ethylcarboxamide-induced migration and proliferation of mouse embryonic stem cells.
Kim MO; Lee YJ; Han HJ
J Cell Physiol; 2010 Jul; 224(1):187-94. PubMed ID: 20232318
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study.
Zhang L; Li Y; Lan L; Liu R; Wu Y; Qu Q; Wen K
Mol Cell Endocrinol; 2016 Dec; 437():51-61. PubMed ID: 27519631
[TBL] [Abstract][Full Text] [Related]
39. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
40. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW; Nambirajan S; Moffat JG
Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
